000 01175 a2200337 4500
005 20250516152919.0
264 0 _c20130917
008 201309s 0 0 eng d
022 _a1873-5835
024 7 _a10.1016/j.leukres.2013.05.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPieri, Lisa
245 0 0 _aThe burden of symptoms in myelofibrosis: from patient-reported outcomes to health economics.
_h[electronic resource]
260 _bLeukemia research
_cAug 2013
300 _a855-6 p.
_bdigital
500 _aPublication Type: Editorial; Research Support, Non-U.S. Gov't
650 0 4 _aCost of Illness
650 0 4 _aHealth Care Costs
650 0 4 _aHumans
650 0 4 _aJanus Kinases
_xantagonists & inhibitors
650 0 4 _aNitriles
650 0 4 _aPrimary Myelofibrosis
_xdrug therapy
650 0 4 _aPyrazoles
_xeconomics
650 0 4 _aPyrimidines
650 0 4 _aQuality of Life
650 0 4 _aTreatment Outcome
700 1 _aLoiacono, Idalba
700 1 _aVannucchi, Alessandro M
773 0 _tLeukemia research
_gvol. 37
_gno. 8
_gp. 855-6
856 4 0 _uhttps://doi.org/10.1016/j.leukres.2013.05.009
_zAvailable from publisher's website
999 _c22798294
_d22798294